Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-045416
Filing Date
2025-05-07
Accepted
2025-05-07 11:48:22
Documents
1
Period of Report
2024-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2514116-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2514116-1_4aseq1.xml 4/A 26086
  Complete submission text file 0001104659-25-045416.txt   27845
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Reporting) CIK: 0001448698 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-11460 | Film No.: 25920125